首页 | 本学科首页   官方微博 | 高级检索  
检索        


Vaccine introduction in the Democratic People's Republic of Korea
Institution:1. International Vaccine Institute, Seoul, Republic of Korea;2. Dept. of Epidemiology, School of Public Health, Fudan University, Shanghai, China;1. International Vaccine Institute, Seoul, Republic of Korea;3. Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA;4. Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany;5. Institute of Tropical Medicine, Eberhard-Karls University, Tübingen, Germany;1. Center for Immunobiology and Vaccine Development, Children''s Hospital Oakland Research Institute, Oakland, CA 94609, USA;2. Department of Molecular Genetics, University of Toronto, Toronto, ON, M55 1A8 Canada;1. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, United States;2. Department of Medicine, Arizona Cancer Center, Tucson, AZ, United States;3. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States;4. Department of Preventive Medicine, School of Medicine, State University of New York at Stony Brook, Stony Brook, NY, United States;5. Departments of Epidemiology and Medicine, Brown University, Providence, RI, United States;6. Department of Public Health Sciences, School of Medicine, University of California at Davis, Davis, CA, United States;7. Karmanos Cancer Institute, Detroit, MI, United States;8. Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, United States;1. CEA, Division of Immuno-Virology, IDMIT Center, iMETI/DSV, Fontenay-aux-Roses, France;2. UMR-1184, Université Paris Sud 11, Orsay, France;3. Vaccine Research Institute (VRI), Créteil, France;4. INSERM, Paris, France;5. Bertin Pharma, Montigny-Le-Bretonneux, France;6. INSERM, Unite U955, Créteil F-94010, France;7. Université Paris-Est, Faculté de Médecine, Hôpital Albert-Chenevier, Créteil F-94010, France;8. Hôpital Henri-Mondor, Service d’Immunologie clinique, UMR-S 955, Créteil F-94010, France;1. Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany;2. TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany;3. African Population and Health Research Center, Nairobi, Kenya;4. Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany;5. Hannover Medical School, Hannover, Germany;6. Department of Biometry, Epidemiology and Information Processing, University for Veterinary Medicine, Hanover, Germany;1. Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald-Insel Riems, Germany;2. Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Suedufer 10, 17493 Greifswald-Insel Riems, Germany
Abstract:The feasibility of mass vaccination campaigns for Japanese encephalitis and Haemophilus influenzae type b infections was explored in the Democratic People's Republic of Korea using pilot vaccination studies. The experiences from these initial studies were then used to support larger vaccination campaigns in children at risk of these infections. We discuss the challenges and requirements for the inclusion of additional vaccines into the existing expanded program on immunization in the country.
Keywords:DPR Korea  Japanese encephalitis  Vaccination  Vaccine introduction  Disease burden  DPRK
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号